BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6086847)

  • 1. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
    Jones FR; Grant CK; Snyder HW
    J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
    Snyder HW; Singhal MC; Hardy WD; Jones FR
    J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
    Snyder HW; Reed DE; Jones FR
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of protein A administered intravenously to pet cats with leukemia or lymphosarcoma.
    Harper HD; Sjöquist J; Hardy WD; Jones FR
    Cancer; 1985 May; 55(9):1863-7. PubMed ID: 2983866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious spread and control of feline leukemia virus.
    Hardy WD; McClelland AJ
    Transplant Proc; 1975 Jun; 7(2):265-7. PubMed ID: 165603
    [No Abstract]   [Full Text] [Related]  

  • 6. Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with staphylococcal protein A.
    Engelman RW; Good RA; Day NK
    Cancer Detect Prev; 1987; 10(5-6):435-44. PubMed ID: 3032440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption.
    Snyder HW; Jones FR; Day NK; Hardy WD
    J Immunol; 1982 Jun; 128(6):2726-30. PubMed ID: 6281336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.
    Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG
    Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of lymphoma leukemia in cats following ex vivo immunosorption therapy using Staphylococcus protein A.
    Day NK; Engelman RW; Liu WT; Trang L; Good RA
    J Biol Response Mod; 1984; 3(3):278-85. PubMed ID: 6086846
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of infection with feline leukemia virus in cats].
    Theilen GH
    Tierarztl Prax; 1984; 12(4):511-22. PubMed ID: 6098972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of feline leukemia virus in the natural environment.
    Hardy WD; Hess PW; MacEwen EG; McClelland AJ; Zuckerman EE; Essex M; Cotter SM; Jarrett O
    Cancer Res; 1976 Feb; 36(2 pt 2):582-8. PubMed ID: 175919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline leukemia virus research- an update.
    Hadden JW
    Clin Bull; 1975; 5(4):163-4. PubMed ID: 179729
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats.
    Day NK; O'Reilly-Felice C; Hardy WD; Good RA; Witkin SS
    J Immunol; 1980 Dec; 125(6):2363-6. PubMed ID: 6253567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H; Pedersen NC; Theilen GH
    Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A; Grófová M
    Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.
    Engelman RW; Tyler RD; Trang LQ; Liu WT; Good RA; Day NK
    Am J Pathol; 1985 Mar; 118(3):367-78. PubMed ID: 2983560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.
    Lafrado LJ; Mathes LE; Zack PM; Olsen RG
    Am J Vet Res; 1990 Mar; 51(3):482-6. PubMed ID: 1690524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.
    Jackson ML; Wood SL; Misra V; Haines DM
    Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of feline lymphosarcoma with feline blood constituents.
    Hardy WD; Hess PW; MacEwen EG; Hayes AA; Kassel RL; Day NK; Old LJ
    Bibl Haematol; 1975 Oct; (43):518-21. PubMed ID: 183721
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of suramin on serum viral replication in feline leukemia virus-infected pet cats.
    Cogan DC; Cotter SM; Kitchen LW
    Am J Vet Res; 1986 Oct; 47(10):2230-2. PubMed ID: 3022623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.